Equities labeled as highly volatile typically include early-stage clinical biotechnology firms, highly speculative small-cap technology stocks, highly leveraged companies, and leveraged exchange-traded funds (ETFs). These instruments frequently experience extreme intraday price movements driven by sentiment shifts, regulatory approvals, or sudden liquidity fluctuations.